Skip to main contentSkip to navigation
Print subscriptions
Sign in
Search jobs
Search
The Guardian - Back to homeThe Guardian

AstraZeneca

May 2024

  • Nils Pratley

    Nils Pratley on finance
    Will AstraZeneca be the UK’s first £200bn company?

    Nils Pratley
  • Test tubes are seen in front of an AstraZeneca logo

    AstraZeneca aims to nearly double revenues to $80bn by 2030

  • Gloved hand holds vial with AstraZeneca vaccine label

    AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

  • AstraZeneca vaccines

    AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines

April 2024

  • Nils Pratley

    Nils Pratley on finance
    The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca

    Nils Pratley
  • Pascal Soriot speaking at a podium bearing the sign 'Invest in China Summit 2024'

    AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion

March 2024

  • AstraZeneca Covid-19 vaccine bottle next to a syringe

    AstraZeneca claims Australian rules stopped it defending its vaccine during pandemic

  • Test tubes in front of an AstraZeneca logo

    AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn

  • Composite of Pascal Soriot and Sundar Pichai over a backdrop of novelty £1m dollar notes

    When £17m isn’t enough: FTSE firms plead to pay bosses millions more

  • Emma Walmsley smiles as she sits by a window

    GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

February 2024

  • Pascal Soriot, the chief executive of AstraZeneca.

    AstraZeneca boss’s £17m pay package under fire

  • Illustrations of Wegovy injector pens in Chicago

    Weight-loss drugs need to become cheaper, says AstraZeneca boss

December 2023

  • Felix Munkonge

    Other lives
    Felix Munkonge obituary

    Other lives: Specialist in cell biology who helped with the development of a Covid-19 vaccine and treatments for cystic fibrosis
  • Cancer cells revealed by fluorescence imaging

    AstraZeneca buys Chinese cancer therapy firm Gracell for $1.2bn

    Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker
  • Test tubes are seen in front of a displayed AstraZeneca logo.

    AstraZeneca buys US vaccine company in $1.1bn deal

    Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

November 2023

  • The AstraZeneca booth at the China International Import Expo in Shanghai this month.

    AstraZeneca makes big push into weight-loss market with obesity pill deal

    UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

August 2023

  • Boats anchored in the River Thames, with buildings in the City of London financial district behind them

    FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’

    CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation

July 2023

  • Pascal Soriot in a suit but no tie poses with his hands in his pocket by some lush greenery in a conservatory

    Observer business profile
    Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

    The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution
  • Hospital worker in ward

    ‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

    Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest
  • A company logo is seen at the AstraZeneca site in Macclesfield, Britain

    AstraZeneca stock value falls by nearly £14bn after cancer drug trial results

    Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped
About 1,062 results for AstraZeneca
1234...
Explore more on these topics
  翻译：